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OBJECTIVE—Recent genome-wide association studies (GWAS)
revealed that a 9p21.3 locus was associated with type 2 diabetes. In
this study, we carried out a large-scale case-control study in the
GeneID Chinese Han population to 1) further replicate the associ-
ation of 9p21.3 type 2 diabetes GWAS single nucleotide polymor-
phisms (SNPs) and 2) assess the association of these SNPs with
coronary artery disease.
RESEARCH DESIGN AND METHODS—Three SNPs (rs2383208,
rs10811661, and rs10757283) were genotyped in two GeneID
cohorts of 3,167 Chinese Han individuals. Case-control association
design was used to determine the association of the SNPs with type
2 diabetes and coronary artery disease. Gensini scores were
calculated in the coronary artery disease subjects and were tested
for association with the variants. Multivariate logistic regressions
were performed on association studies.
RESULTS—The association between two of the three SNPs and
type 2 diabetes was replicated in the GeneID population
(rs2383208, P = 0.936; rs10811661-T, P = 0.02, odds ratio [OR] =
1.23; rs10757283-C, P = 0.003, OR = 1.30). The same two SNPs also
contributed to the risk of coronary artery disease (CAD)
(rs10811661-T, P = 0.002, OR = 1.19; rs10757283-C, P = 0.003,
OR = 1.18). In addition, rs10757283 was associated with severity
of coronary atherosclerosis estimated by the Gensini scoring sys-
tem (risk allele C, quantitative-trait regression adjusted P = 0.002).
CONCLUSIONS—For the ﬁrst time to our knowledge, our
results indicated that the same 9p21.3 locus, represented by
SNPs rs10811661 and rs10757283, contributed to the risk of type 2
diabetes and coronary artery disease in our GeneID Chinese Han
population. Diabetes 60:680–684, 2011
T
ype 2 diabetes mellitus and coronary artery dis-
ease (CAD) are both complex diseases that are
caused by interactions among multiple genetic
and environmental factors. Both of them reduce
the quality of life and greatly increase mortality, and mul-
tiple approaches have been developed to understand the
genetic basis of these complex disorders (1,2). Recently,
several genome-wide association studies (GWAS) have
identiﬁed single nucleotide polymorphisms (SNPs) in a
chromosome 9p21.3 region that contributed to risk of
coronary heart disease/myocardial infarction (MI) (3–7)
and type 2 diabetes (5,8–10). The 9p21.3 genetic variants
associated with these two diseases seem to reside on two
adjacent haplotype blocks in this region (44-kb CAD block
from rs10116277 to rs1333049 and 4-kb type 2 diabetes
block from rs10965243 to rs10757283) (11). Two recent
studies with European populations suggested that these
two blocks may be associated with the two diseases in-
dependently (12,13). One SNP, rs10811661, has been rep-
licated of type 2 diabetes risk in East Asian populations
(14–19) including Chinese (20,21). It was thought that type
2 diabetes and CAD may share common genetic and en-
vironmental antecedents (22,23). Whether this diabetic
region contributes to both type 2 diabetes and CAD risk
needs to be studied. In this study, we carried out a large-
scale case-control study in our GeneID Chinese Han pop-
ulation to assess the association of three type 2 diabetes
GWAS SNPs—rs2383208, rs10811661, and rs10757283—
with type 2 diabetes and CAD.
RESEARCH DESIGN AND METHODS
Study subjects. All participants in this study were selected from the GeneID
database (24), which enrolls study subjects with the same Han ethnic origin
from several hospitals in Central China (individuals enrolled in hospitals in
Wuhan city were from Hubei province, Hunan province, Anhui province, and
Henan province) and Northern China (individuals enrolled in hospitals in
Jining, Harbin, and Beijing cities were from Shandong province, Heilongjiang
province, and Beijing city). The study followed the principals outlined in the
Declaration of Helsinki and has been approved by the local institutional re-
view boards. Written informed consents were acquired from all participants.
The GeneID-Central-China cohort was used as the discovery sample to test the
association of the 9p21.3 locus with type 2 diabetes and CAD. The GeneID-
Northern-China cohort was used as the replication population. Blood samples
were drawn from the peripheral vein, and genomic DNA was isolated by using
Wizard Genomic DNA Puriﬁcation Kit (Promega Corporation, Madison, WI).
Diagnostic criteria of type 2 diabetes and CAD. Type 2 diabetes was di-
agnosed as features of diabetes with a plasma glucose level of $200 mg/dL
(11.1 mmol/L), or a fasting plasma glucose concentration of $126 mg/dL (7.0
mmol/L) after at least 8 h fasting, or a 2-h plasma glucose level of $200 mg/dL
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ORIGINAL ARTICLE(11.1 mmol/L) during an oral glucose tolerance test (OGTT) (25). Each glucose
test was performed again at the subsequent day to conﬁrm the diagnosis. CAD
was deﬁned as angiographically demonstrated stenosis of more than 70% in a
major or a main branch of the coronary artery (26). All participants had un-
dertaken both an OGTT and coronary angiography. Each subject was classi-
ﬁed into one of the following groups: 1) type 2 diabetes group, which
comprised type 2 diabetes patients without stenosis in coronary arteries.
Patients who had a MI record were also excluded from the type 2 diabetes
group (27); 2) CAD group, which comprised CAD patients without abnormal
blood glucose levels; and 3) control group, which comprised individuals who
had neither abnormal blood glucose levels nor stenosis in any coronary artery.
Individuals older than 80 years or younger than 30 years were excluded from
this study.
Other clinical data. Data on age, sex, smoking, and smoking history were
collected from the participants’ medical records or by direct interviews. Hy-
pertension was diagnosed as a blood pressure of higher than 140/90 mmHg,
which was measured according to guidelines (28). Fasting concentrations of
the total cholesterol (Tch), triglyceride (TG), LDL cholesterol (LDL-c), and
HDL cholesterol (HDL-c) were measured using standard methods (29).
Gensini scores.Severityofcoronaryatherosclerosiswascalculated according
to the Gensini scoring system (30). In each segment, the narrowing of the
coronary artery lumen is rated 1 for 0–25% stenosis, 2 for 26–50%, 4 for 51–
75%, 8 for 76–90%, 16 for 91–99%, and 32 for 100%. Each stenosis score is
multiplied by a factor, which is assigned to each coronary segment depending
on vessel size and importance (ranging from 0.5 to 5.0). Each patient’s Gensini
index is the sum of the total weights for each segment. The association be-
tween Gensini scores and the three SNPs was assessed by treating the Gensini
scores as a quantitative trait or using quartile case-control methods (31).
SNP selection and genotyping. We analyzed three GWAS suggestive SNPs—
rs2383208, rs10811661, and rs10757283—covering the previously reported
type 2 diabetic-risk region. They were selected according to type 2 diabetes
GWAS reported by Scott et al. (rs2383208 and rs10811661) (8), Takeuchi et al.
(rs2383208) (18), and Zeggini et al. (rs10811661 and rs10757283) (9).
All study individuals were genotyped for these three SNPs using a Rotor-
Gene 6000 High-Resolution Melt (HRM) system (Corbett Life Science, Con-
corde, NSW, Australia). Genotyping was performed in a total of 25 mL PCR
volume containing 1 mL of LC Green dye, 5 pmol of each primer, 25 ng of
genomic DNA, 2.5 mLo f1 0 3 PCR buffer with 1.5 mmol/L MgCl2, 5 mmol
deoxynucleotide triphosphates, and 1 unit of Taq polymerase. Two positive
controls for each genotype were included in each run. For each SNP, a total of
48 cases and controls were randomly selected for veriﬁcation of genotyping
results using direct DNA sequencing analysis. DNA sequence analysis was
performed with forward and/or reverse primers using the BigDye Terminator
v3.1 Cycle Sequencing Kits on an ABI PRISM 3100 Genetic Analyzer (Applied
Biosystems, Foster City, CA).
Statistical analysis. A statistical power analysis was performed using PS
software version 3.0.2 for a case-control design (32). Hardy-Weinberg equi-
librium tests were carried out for each SNP among control groups by using
PLINK software version 1.05 (33). Allelic and genotypic associations of SNPs
with a binary disease trait were assessed using Pearson’s23 2 and 2 3 3
contingency table x
2 tests (PLINK). Odds ratios (ORs) and 95% conﬁdence
intervals (CI) were estimated using x
2 tests (PLINK). Multivariate analysis was
performed by incorporating age, sex, hypertension, smoking history, Tch, TG,
HDL-c, and LDL-c level as covariates by using multivariate logistic regression
(PLINK). Gensini scores P-P plot was generated by SPSS v13.0 to test for
normal distribution. The quantitative trait association of Gensini scores was
calculated after loge-transformation (PLINK). All CAD patients were classiﬁed
into quartiles of Gensini score levels. The ﬁrst (lowest) and the fourth
(highest) quartile were selected to carry out a case-control SNP association
analysis. Linkage disequilibrium (LD) block patterns were constructed by
Haploview software version 4.0 based on r
2 values.
RESULTS
Population characteristics and power analysis. Two
cohorts of study subjects were studied, and they are the
GeneID-Central-China cohort and GeneID-Northern-China
cohort. Table 1 shows the detailed clinical features of the
two cohorts. Among a total of 1,724 individuals in the
GeneID-Central-China cohort, 379 were diagnosed as type
2 diabetic cases, 496 as CAD cases, and 849 as controls.
Mean ages (with standard deviations) of the three groups
were 55.3 6 11.4, 60.6 6 10.7, and 54.6 6 13.2, re-
spectively. Proportions of men were 57.0, 64.9, and 46.6%,
respectively. The GeneID-Northern-China cohort consisted
of 1,443 individuals, of whom 597 were CAD cases and 846
were controls. Mean ages (with standard deviation) were
60.8 6 11.3 for the CAD group and 55.4 6 14.0 for the
control group.
Under the population parameter settings of the effect size
(OR of 1.3 for type 2 diabetes and 1.2 for CAD) (17,18,34–
36), an allelic frequency of 0.37 (HapMap CHB data, the
minimum minor allele frequency (MAF) among the three
SNPs was 0.37 for rs10757283) and nominal Type I error
of 0.05, our sample size for type 2 diabetes can provide
83.8% of statistical power and the CAD samples size can
provide 90.7% power. The power analysis indicated that our
GeneID sample sizes were sufﬁcient to test the association
between the 9p21.3 locus and type 2 diabetes and CAD.
9p21.3 SNPs were associated with type 2 diabetes in
a Chinese Han GeneID population. The call rate was
100% for three SNPs in all samples. All three SNPs gained
quality control results of 100% according to 48 random
selected DNA samples direct sequencing veriﬁcation of
HRM genotyping for each SNP. There was no deviation
from the Hardy-Weinberg equilibrium for the three 9p21.3
TABLE 1
Clinical characteristics of the study populations
Characteristics
GeneID-Central-China GeneID-Northern-China
Type 2 diabetes CAD Control CAD Control
n 379 496 849 597 846
Age (years)* 55.3 6 11.4 60.6 6 10.7 54.6 6 13.2 60.8 6 11.3 55.4 6 14.0
Sex (% men) 57.0 64.9 46.6 60.6 48.1
Smoking (%) 28.2 34.8 11.7 47.6 16.1
Fasting plasma glucose (mmol/L) 5.0 6 0.8 4.9 6 0.6 4.8 6 0.7 4.8 6 0.8
2-Hour plasma glucose (mmol/L) 6.0 6 1.3 5.8 6 1.5 5.6 6 1.6 5.7 6 1.1
BMI (kg/m
2) 24.6 6 4.3 24.0 6 3.2 23.5 6 3.5 24.3 6 3.5 23.8 6 3.0
Hypertension (%) 66.0 56.7 4.6 61.7 7.0
Tch (mmol/L) 4.63 6 1.16 4.31 6 1.15 4.20 6 1.12 4.86 6 0.98 4.60 6 0.92
TG (mmol/L) 1.94 6 1.03 1.89 6 1.28 1.72 6 1.28 2.05 6 1.12 1.98 6 1.52
HDL-c (mmol/L) 1.11 6 0.37 1.17 6 0.60 1.22 6 0.31 1.08 6 0.38 1.12 6 0.32
LDL-c (mmol/L) 2.71 6 0.83 2.60 6 0.87 2.37 6 0.73 3.11 6 0.90 2.92 6 0.86
Gensini score 30.2 6 28.9 28.5 6 25.2
Data are presented as means 6 SD or percent. *Age for the case group refers to age at diagnosis; age for the control group refers to age at
which the study subject was enrolled.
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showed signiﬁcant association with type 2 diabetes in the
GeneID-Central population (rs10811661-T, P = 0.02, OR =
1.23, 95% CI 1.03–1.47; rs10757283-C, P = 0.003, OR = 1.30,
95% CI 1.09–1.54) (Table 2). Signiﬁcant genotypic associ-
ation was also found between these two variants and type
2 diabetes (additive model P values after adjustment for
covariates of 0.006 for both SNPs) (Supplementary Table 1).
Association of rs2383208 was not signiﬁcant in neither
allelic (P = 0.936) nor genotypic association (additive
model P = 0.468) with disease (Table 2 and Supplementary
Table 1). All P values retained their initial signiﬁcance
status after multivariate logistic regression (adjustive
P values in Table 2 and Supplementary Table 1).
The three 9p21.3 SNPs were associated with CAD in
Chinese GeneID cohorts. In GeneID-Central-China co-
hort, rs10811661 and rs10757283 showed signiﬁcant allelic
association with CAD (P = 0.030 and 0.026, respectively),
whereas no allelic association was detected for SNP
rs2383208 (P = 0.259) (Table 2). The CAD association was
replicated in our GeneID-Northern-China cohort with P
values of 0.028 and 0.039 for rs10811661 and rs10757283,
respectively (Table 2). Association for rs2383208 did not
reach the signiﬁcant level (P = 0.108) (Table 2). In the
combined population of the two GeneID Chinese cohorts,
the CAD association remained signiﬁcant for rs10811661
(T allele, P = 0.002, OR = 1.19, 95% CI 1.06–1.33) and
rs10757283 (C allele, P = 0.003, OR = 1.18, 95% CI 1.06–
1.32) (Table 2). SNP rs2383208 gained a near signiﬁcant
allelic P value of 0.058 (Table 2). For rs10811661 and
rs10757283, signiﬁcant genotypic association was also
found assuming an additive model (P = 5.72 3 10
24 and
0.005, respectively) (Supplementary Table 1). All P values
retained their initial signiﬁcance status after multivariate
logistic regression (adjustive P values in Table 2 and
Supplementary Table 1).
SNP rs10757283 was associated with the Gensini
scores in the Chinese GeneID population. We estimated
the severity of coronary atherosclerosis by the Gensini
scoring system and found that the scores of GeneID CAD
patients followed the normal distribution after natural log
transformation (Supplementary Figs. 1 and 2). When analyzed
as a quantitative trait, signiﬁcant association for severity of
atherosclerosis was found for SNP rs10757283 (observed P =
2.48 3 10
29, adjusted P = 0.002 after logistic regression with
11 clinical traits as covariates) but not for SNPs rs2383208
and rs10811661 (observed P = 0.134 and 0.263, adjusted P =
0.567 and 0.488, respectively, after logistic regression with
11 covariates) (Table 3).
When the distribution of the risk alleles in the highest
and lowest Gensini score quartiles of patients was com-
pared in a case-control design, signiﬁcant association was
obtained again with SNP rs10757283 (observed P =9 . 53
10
210, adjusted P = 0.006 after logistic regression with 11
covariates, OR = 2.09, 95% CI 1.65–2.64) but not with SNPs
rs2383208 and rs10811661 (Table 3).
DISCUSSION
In this study, we carried out an extensional replication
study for the association of a chromosome 9p21.3 locus
tagged by rs2383208, rs10811661, and rs10757283 with type
2 diabetes in a Chinese population, and the results indicate
that this locus confers a signiﬁcant risk of type 2 diabetes
in our GeneID Chinese population. For the ﬁrst time to our
knowledge, this study also demonstrated that this same
diabetic locus was associated with CAD.
The association between rs2383208 and type 2 diabetes
in GWAS reports (8,18) was not replicated in our GeneID
Chinese population in neither allelic nor genotypic analy-
sis. For rs10811661, we further conﬁrmed its genetic risk
on type 2 diabetes in the Chinese population, which was in
accordance with previous studies in both risk allele (major
allele T) and risk effect (OR = 1.2–1.3) (20,21). For SNP
rs10757283, we replicated its association with type 2 di-
abetes for the ﬁrst time in a Chinese Han population. It was
noteworthy that the risk allele of this variant was C in our
GeneID Chinese population instead of T in previously
TABLE 2
Allelic association of 9p21.3 SNPs rs2383208, rs10811661, and rs10757283 with type 2 diabetes and CAD in the Chinese GeneID
population
SNP (risk allele)
Risk AF
P OR (95% CI) P-adj* Case Control
Type 2 diabetes
GeneID-Central-China (379 cases/849 controls)
rs2383208(G) 0.424 0.425 0.936 0.99 (0.84–1.18) 0.806
rs10811661(T) 0.621 0.571 0.020 1.23 (1.03–1.47) 0.021
rs10757283(C) 0.472 0.409 0.003 1.30 (1.09–1.54) 0.004
CAD
GeneID-Central-China (496 cases/849 controls)
rs2383208(G) 0.448 0.425 0.259 1.10 (0.94–1.28) 0.206
rs10811661(T) 0.614 0.571 0.030 1.19 (1.02–1.40) 0.048
rs10757283(C) 0.453 0.409 0.026 1.20 (1.02–1.40) 0.013
GeneID-Northern-China (597 cases/846 controls)
rs2383208(G) 0.437 0.407 0.108 1.13 (0.97–1.31) 0.121
rs10811661(T) 0.609 0.568 0.028 1.18 (1.02–1.38) 0.031
rs10757283(C) 0.446 0.408 0.039 1.17 (1.01–1.36) 0.035
GeneID-combined (1,093 cases/1,695 controls)
rs2383208(G) 0.442 0.416 0.058 1.11 (1.00–1.24) 0.061
rs10811661(T) 0.611 0.570 0.002 1.19 (1.06–1.33) 0.004
rs10757283(C) 0.449 0.408 0.003 1.18 (1.06–1.32) 0.001
AF, allele frequency. *Adjusted P values were obtained using multivariate logistic regression analysis.
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be false positive because of limited sample size, or
10757283 may be only a marker so that the two different
risk alleles in distinct ethical populations are in LD with
the unidentiﬁed causative SNP/gene allele. Thus future
studies are needed in various populations to investigate
the association of rs10757283 with type 2 diabetes.
The association between CAD and chromosome 9p21.3
has been reported and conﬁrmed in various populations.
Most of these CAD-associated SNPs lie in a 44-kb LD block
(11). Our ﬁndings provided the evidence of extensional
association of variants in an adjacent diabetic region with
CAD phenotype. To our knowledge, it is the ﬁrst report
that the same SNPs confer to both type 2 diabetes and
coronary heart disease. To investigate whether these
newly found CAD SNPs are an extension of the previously
reported CAD LD region, we constructed and compared
the linkage disequilibrium pattern of a 150-kb 9p21.3 re-
gion (chromosome 9 from 22.05 to 22.20 Mb containing
previously reported CAD associated locus and type 2 di-
abetic region) based on HapMap data and our GeneID SNP
array data. The results showed that these disease risk
SNPs were in LD in our control samples (Supplementary
Fig. 3). Populations of different ancestry origin showed
a highly consistent LD pattern: there exists a high re-
combination rate interval between these two disease-
associated LD regions (Supplementary Fig. 4). When the
nearest upstream CAD-risk SNP rs1333049 was compared
with the strongest effect SNP rs10757283 in this study, we
found that these two variants seemed to be totally in-
dependent from each other whether examined in HapMap
CEU (D9 = 0.14, r
2 = 0.02), HapMap CHB (D9 = 0.28, r
2 =
0.05), or in our GeneID population (D9 = 0.11, r
2 = 0.01).
These data suggested that these three SNPs might not be in
linkage with the upstream CAD LD block and would con-
tribute to CAD risk independently.
The Gensini scoring system is a well-used method for
measuring the severity of coronary atherosclerosis, which
is the primary pathophysiological process underlying
CAD (37). Because our 1,093 Gensini scores were in ac-
cordance with normal distribution after loge-transformation
(Supplementary Figs. 1 and 2), we performed quantitative
trait association and quartile case-control association
studies for the three 9p21.3 SNPs. For both analyses,
rs10757283 gained signiﬁcant observed P values (risk allele
C, quantitative trait P = 2.48 3 10
29, quartile case-control,
P = 9.50 3 10
210). We also performed logistic regressions
by incorporating as much clinical data as possible (age,
sex, hypertension, smoking history, Tch, TG, HDL-c, and
LDL-c level, BMI, fast glucose, and OGTT as covariates)
(Table 3). The results showed that the association between
Gensini scores and rs10757283 was still signiﬁcant (risk
allele C, quantitative trait P-adj = 0.002, quartile case-
control, P-adj = 0.006, respectively) (Table 3). These sug-
gested that SNP rs10757283 genotype might inﬂuence the
coronary atherosclerosis degree and increase CAD risk in
the Chinese Han population.
Type 2 diabetes and CAD have been thought to share
common genetic and environmental antecedents, de-
scribed as a common soil (22,23). In this study, our ﬁnd-
ings provided possible genetic evidences that the same
genetic variants in a 9p21.3 locus contributed to risk of
both type 2 diabetes and CAD. Despite these ﬁndings, our
case-control association study has limitations that our
results are difﬁcult to reveal the underlying shared caus-
ative molecular mechanism on pathology of these two
disorders. Further studies are needed to focus on the
discovery of potential molecular and physiological path-
ways that involve the two disease development.
In conclusion, our results indicated that the same 9p21.3
locus, represented by SNPs rs10811661 and rs10757283,
contributed to the risk of type 2 diabetes and CAD in our
GeneID Chinese Han population.
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